Clinical Trial Update: RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. [NA]

View source ↗

Summary

RESOLVE-AF is a clinical evaluation of Cortex's Ablacath Mapping Catheter and Ablamap System using electrographic flow mapping to identify extra-pulmonary vein …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Arrhythmia
• Atrial Fibrillation
• Atrial Flutter
• Atrial Tachycardia
• Cardiac Arrhythmia
• Paroxysmal Atrial Fibrillation
• Persistent Atrial Fibrillation

Drugs mentioned

• Ablacath Mapping Catheter
• Ablamap System

Snippet

Sponsor: Cortex | Conditions: Atrial Fibrillation, Atrial Fibrillation, Persistent | NA | Status: ACTIVE_NOT_RECRUITING